DE60222895D1 - Linderung von fehlern in der augenkontrollfunktion - Google Patents

Linderung von fehlern in der augenkontrollfunktion

Info

Publication number
DE60222895D1
DE60222895D1 DE60222895T DE60222895T DE60222895D1 DE 60222895 D1 DE60222895 D1 DE 60222895D1 DE 60222895 T DE60222895 T DE 60222895T DE 60222895 T DE60222895 T DE 60222895T DE 60222895 D1 DE60222895 D1 DE 60222895D1
Authority
DE
Germany
Prior art keywords
errors
treatment
control function
accommodation
eye control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60222895T
Other languages
English (en)
Other versions
DE60222895T2 (de
Inventor
Seiji Hayasaka
Yasunori Nagaki
Takatoshi Uonomi
Mari Sanada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Chemical Industries Co Ltd
Original Assignee
Fuji Chemical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Chemical Industries Co Ltd filed Critical Fuji Chemical Industries Co Ltd
Application granted granted Critical
Publication of DE60222895D1 publication Critical patent/DE60222895D1/de
Publication of DE60222895T2 publication Critical patent/DE60222895T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A23L33/145—Extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40—Colouring or decolouring of foods
    • A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/46—Addition of dyes or pigments, e.g. in combination with optical brighteners using dyes or pigments of microbial or algal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60222895T 2001-05-24 2002-05-23 Linderung von fehlern in der augenkontrollfunktion Expired - Lifetime DE60222895T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001155575 2001-05-24
JP2001155575 2001-05-24
PCT/JP2002/005011 WO2002094253A1 (fr) 2001-05-24 2002-05-23 Agents attenuant une erreur de fonction de controle de l'oeil

Publications (2)

Publication Number Publication Date
DE60222895D1 true DE60222895D1 (de) 2007-11-22
DE60222895T2 DE60222895T2 (de) 2008-07-24

Family

ID=18999737

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222895T Expired - Lifetime DE60222895T2 (de) 2001-05-24 2002-05-23 Linderung von fehlern in der augenkontrollfunktion

Country Status (7)

Country Link
US (2) US20040170667A1 (de)
EP (1) EP1396264B1 (de)
JP (1) JP3778509B2 (de)
AT (1) ATE375151T1 (de)
DE (1) DE60222895T2 (de)
ES (1) ES2292754T3 (de)
WO (1) WO2002094253A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4933097B2 (ja) 2003-12-19 2012-05-16 株式会社メニコン 糖尿病および糖尿病合併症の治療・改善方法
FR2882894B1 (fr) * 2005-03-11 2009-04-03 Larena Sa Composition alimentaire suppletive
US20070135521A1 (en) * 2005-12-14 2007-06-14 Yamaha Hatsudoki Kabushiki Kaisha Agent for Preventing Metabolic Syndrome
WO2007141898A1 (ja) * 2006-06-02 2007-12-13 Riken Vitamin Co., Ltd. 眼精疲労改善剤
JP2008035714A (ja) * 2006-08-01 2008-02-21 Wakasa Seikatsu:Kk 健康食品
JP2010270095A (ja) * 2008-05-30 2010-12-02 Yamaha Motor Co Ltd 認知行動能力向上剤
CN104055122A (zh) * 2014-07-09 2014-09-24 江西维莱营健高科有限公司 一种雨生红球藻蓝莓提取物软胶囊及其制备方法
JP6414895B2 (ja) * 2015-06-30 2018-10-31 株式会社 伊藤園 アスタキサンチンを含有する果汁含有飲料及びその製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527533A (en) * 1994-10-27 1996-06-18 Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
JPH10276721A (ja) * 1997-04-11 1998-10-20 Suntory Ltd アスタキサンチン含有飲食物
US5955102A (en) * 1998-09-04 1999-09-21 Amway Corporation Softgel capsule containing DHA and antioxidants
NL1010351C2 (nl) * 1998-10-19 2001-01-08 Werklust & Beheer B V Esters van caroteno´den voor gebruik in de preventie en behandeling van oogaandoeningen.
JP2002017295A (ja) * 2000-07-05 2002-01-22 Yamagami Suehito 眼疾患改善作用及び眼の機能維持作用を有する健康補助食品

Also Published As

Publication number Publication date
JP3778509B2 (ja) 2006-05-24
DE60222895T2 (de) 2008-07-24
EP1396264A4 (de) 2005-10-19
ATE375151T1 (de) 2007-10-15
US20050171214A1 (en) 2005-08-04
ES2292754T3 (es) 2008-03-16
JPWO2002094253A1 (ja) 2004-09-02
WO2002094253A1 (fr) 2002-11-28
EP1396264B1 (de) 2007-10-10
US20040170667A1 (en) 2004-09-02
EP1396264A1 (de) 2004-03-10

Similar Documents

Publication Publication Date Title
DE60336754D1 (de) Enzymbehandlung von nahrungsmitteln für zöliakie-sprue
EP2248430A3 (de) Nahrungsmittel mit probiotischem und isoliertem Beta-Glucan und Verwendungsverfahren dafür
WO2003101397A3 (en) Tetravalent dengue vaccines
DE502005011119D1 (de)
WO2004006858A3 (en) Compounds, compositions, and methods employing same
WO2003039404A3 (en) Methods for treating ocular neovascular diseases
CY1110353T1 (el) Ανοσορρυθμιστικοι ολιγοσακχαριτες
ATE429156T1 (de) Nahrungsergänzung zur behandlung von makula degeneration
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
CY1107174T1 (el) Συνδυασμοι εζετιμιβε με ασπιρινη για θεραπεια αγγειακων καταστασεων
WO2007056457A3 (en) Methods, compositions, and kits for the treatment of medical conditions
TW200736253A (en) Pyridopyrazine derivatives and their use
CY1110894T1 (el) Μεθοδοι για θεραπεια ή προληψη αγγειακης φλεγμονης χρησιμοποιωντας αναστολεα (-εις) απορροφησης στερολης
WO2003092584A3 (en) Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
DE60222895D1 (de) Linderung von fehlern in der augenkontrollfunktion
HRP20050075A2 (en) Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
WO2006078336A3 (en) Compositions and methods for the treatment and prevention of hyperproliferative diseases
WO2005023195A3 (en) Treatment of spinal cord injury
WO2004110373A3 (en) Therapeutic vaccine compositions for the treatment of type 1 diabetes
WO2003070169A3 (en) Aminodiphosphonate apolipoprotein e modulators
WO2004006830A3 (en) Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
WO2004112690A3 (en) 2-aminobenzoyl derivatives
WO2003002062A3 (en) Bis-aryl thiazole derivatives
WO2006100413A3 (fr) Nouveaux composes derives du 5-thioxylose et leur utilisation therapeutique

Legal Events

Date Code Title Description
8364 No opposition during term of opposition